OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 0.9700
-0.0050 (-0.51%)
Sep 17, 2026, 4:10 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 35.6 million as of September 17, 2026. Its market cap has increased by 15.32% in one year.
Market Cap
35.60M
Enterprise Value
29.14M
Revenue
5.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.97
ChartMarket Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 35.60M, an increase of 388.05%. That is a compound annual growth rate of 7.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 35.60M | 94.28% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 73.62M |
| Epiminder | 60.67M |
| Cyclopharm | 60.35M |
| Compumedics | 46.94M |
| HeraMED | 45.19M |
| Cleo Diagnostics | 42.50M |
| Nova Eye Medical | 37.03M |
| Control Bionics | 33.13M |